January 21, 2017 1:24 PM ET

Pharmaceuticals

Company Overview of Cephalon, Inc.

Key Executives for Cephalon, Inc.

NameBoard RelationshipsTitleAge
Wilhelmus Groenhuysen 12 RelationshipsChief Financial Officer, Principal Accounting Officer and Executive Vice President58
Alain Aragues No RelationshipsExecutive Vice President and President of Cephalon Europe Operations64
Valli F. Baldassano Esq.83 RelationshipsChief Compliance Officer and Executive Vice President55
Lesley Russell Cooper M.D., MB. CH.B., MRCP25 RelationshipsChief Medical Officer and Executive Vice President55
Peter E. Grebow Ph.D.30 RelationshipsExecutive Vice President of Cephalon Ventures69
View More Key Executives

Cephalon, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Martyn D. Greenacre MBA 29 RelationshipsAcusphere, Inc.74
Dennis L. Winger 27 RelationshipsAccuray Incorporated68
William P. Egan 44 RelationshipsAlta Equity Partners70
Kevin E. Moley 17 RelationshipsHealthy Communities Institute Corporation69
Gail R. Wilensky Ph.D. 112 RelationshipsWorld Health Organization72
View All Board Members

Cephalon, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Dennis L. Winger27 Relationships3 Executives
Nominating Committee MBAMartyn D. Greenacre29 Relationships3 Executives
Corporate Governance Committee MBAMartyn D. Greenacre29 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
389.2K
Bonus
484.0K
Total Short Term Compensation
566.1K
Total Value of Options
14.8M
Compensation as of Fiscal Year
Cephalon, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Generex Biotechnology Corporation Announces Management Changes
January 20, 2017 9:02 PM ET
Ipsen Appoints Harout Semerjian as President, Head of Specialty Care International Region & Global Franchises, Effective February 2, 2017
January 20, 2017 7:00 AM ET
Sanjivani Paranteral Ltd Announces Resignation of Directors
January 20, 2017 4:53 AM ET
Marinus Pharmaceuticals, Inc. Announces Executive Changes
January 19, 2017 10:16 PM ET
Stealth BioTherapeutics Incorporated Announces Management Appointments
January 19, 2017 2:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cephalon, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.